JFS Wealth Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131 Buy
+4
New +$144 ﹤0.01% 2207
2025
Q4
Sell
-7
Closed -$330 1928
2025
Q3
$330 Sell
7
-3
-30% -$156 ﹤0.01% 1806
2025
Q2
$521 Sell
10
-4
-29% -$220 ﹤0.01% 1693
2025
Q1
$846 Buy
+14
New +$902 ﹤0.01% 1676
2024
Q4
Sell
-3
Closed -$216 1956
2024
Q3
$216 Sell
3
-2
-40% -$141 ﹤0.01% 1862
2024
Q2
$347 Sell
5
-5
-50% -$365 ﹤0.01% 1850
2024
Q1
$801 Sell
10
-4
-29% -$357 ﹤0.01% 1708
2023
Q4
$1.53K Buy
14
+4
+40% +$414 ﹤0.01% 1531
2023
Q3
$1.01K Sell
10
-3
-23% -$345 ﹤0.01% 1594
2023
Q2
$1.77K Buy
13
+4
+44% +$488 ﹤0.01% 1428
2023
Q1
$935 Sell
9
-1
-10% -$97 ﹤0.01% 1602
2022
Q4
$886 Buy
10
+2
+25% +$166 ﹤0.01% 1630
2022
Q3
$1K Buy
8
+5
+167% +$472 ﹤0.01% 1512
2022
Q2
$0 Sell
3
-10
-77% -$1.2K ﹤0.01% 1777
2022
Q1
$2K Buy
13
+8
+160% +$1.12K ﹤0.01% 1390
2021
Q4
$1K Buy
+5
New +$708 ﹤0.01% 1299

Other funds holding CNMD

JFS Wealth Advisors's CNMD Position: Q2 2026 in Review

JFS Wealth Advisors opened a new position in CONMED (CNMD) in Q2 2026: 4 shares worth $131. The stake represents ﹤0.01% of the portfolio and ranks #2207 among its holdings. This is a return to the name: JFS Wealth Advisors previously reported a position in CNMD as recently as Q3 2025.

JFS Wealth Advisors first reported a position in CNMD in Q4 2021 and has held it in 16 quarters since. The position peaked at $2K in Q1 2022. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • JFS Wealth Advisors held 4 shares of CONMED worth $131 as of Q2 2026.
  • CONMED was a new JFS Wealth Advisors position in Q2 2026.
  • CONMED made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2207 holding.
  • JFS Wealth Advisors first reported a position in CONMED in Q4 2021 and has held it in 16 quarters since.
  • JFS Wealth Advisors's CONMED position peaked at $2K in Q1 2022.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.